Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals
dc.authorid | Bayindir, Yasar/0000-0003-3930-774X | |
dc.authorid | ARITURK, Seda/0000-0002-8559-4148 | |
dc.authorwosid | Bayindir, Yasar/T-1523-2017 | |
dc.authorwosid | ARITURK, Seda/KOD-4936-2024 | |
dc.contributor.author | Sönmez, E | |
dc.contributor.author | Sönmez, AS | |
dc.contributor.author | Bayindir, Y | |
dc.contributor.author | Coskun, D | |
dc.contributor.author | Aritürk, S | |
dc.date.accessioned | 2024-08-04T20:13:11Z | |
dc.date.available | 2024-08-04T20:13:11Z | |
dc.date.issued | 2002 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | In this prospective study, our aim was to test the effect of simultaneous administration of preS2 and S containing recombinant hepatitis B vaccine (S2SRHB) with tetanus toxoid (TT) to the individuals who did not respond after three doses of hepatitis B vaccine previously. There were three groups (healthy individuals, pregnant women, hemodialysis patients), each was divided into two subgroups as groups A and B. Group A received S2SRHB + TT and group B received only S2SRHB. We found that in groups receiving both vaccines, both seroconversion rate and antibody titer level were significantly higher (P < 0.05). In conclusion, simultaneous administration of S2SRHB + TT is more effective than administration of S2SRHB alone. (C) 2002 Elsevier Science Ltd. All rights reserved. | en_US |
dc.identifier.doi | 10.1016/S0264-410X(02)00452-8 | |
dc.identifier.endpage | 246 | en_US |
dc.identifier.issn | 0264-410X | |
dc.identifier.issn | 1873-2518 | |
dc.identifier.issue | 3-4 | en_US |
dc.identifier.pmid | 12450699 | en_US |
dc.identifier.scopus | 2-s2.0-0037073575 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 243 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0264-410X(02)00452-8 | |
dc.identifier.uri | https://hdl.handle.net/11616/93462 | |
dc.identifier.volume | 21 | en_US |
dc.identifier.wos | WOS:000179723900012 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Sci Ltd | en_US |
dc.relation.ispartof | Vaccine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | hepatitis B vaccine | en_US |
dc.subject | tetanus toxoid | en_US |
dc.subject | nonresponder | en_US |
dc.title | Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals | en_US |
dc.type | Article | en_US |